Genomic programming of human neonatal dendritic cells in congenital systemic and in vitro cytomegalovirus infection reveal plastic and robust immune pathway biology responses by Alsheikhly Dantoft, Widad et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genomic programming of human neonatal dendritic cells in
congenital systemic and in vitro cytomegalovirus infection reveal
plastic and robust immune pathway biology responses
Citation for published version:
Alsheikhly Dantoft, W, Martinez, P, Jafali, J, Perez-Martinez, L, Martin, K, Kotzamanis, K, Craigon, M, Auer,
M, Young, N, Walsh, P, Marchant, A, Forster, T & Ghazal, P 2017, 'Genomic programming of human
neonatal dendritic cells in congenital systemic and in vitro cytomegalovirus infection reveal plastic and
robust immune pathway biology responses' Frontiers in Immunology. DOI: 10.3389/fimmu.2017.01146
Digital Object Identifier (DOI):
10.3389/fimmu.2017.01146
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Frontiers in Immunology
Publisher Rights Statement:
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these terms.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
September 2017 | Volume 8 | Article 11461
Original research
published: 25 September 2017
doi: 10.3389/fimmu.2017.01146
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Catherine Thornton, 
Swansea University, 
United Kingdom
Reviewed by: 
Elena Monica Borroni, 
Humanitas Research Hospital, Italy 
David Dombrowicz, 
Institut national de la santé 
et de la recherche médicale, 
France
*Correspondence:
Widad Dantoft 
widad.dantoft@ed.ac.uk; 
Peter Ghazal 
p.ghazal@ed.ac.uk
†These authors have contributed 
equally to this work.
Specialty section: 
This article was submitted 
to Inflammation, 
a section of the journal 
Frontiers in Immunology
Received: 26 May 2017
Accepted: 30 August 2017
Published: 25 September 2017
Citation: 
Dantoft W, Martínez-Vicente P, 
Jafali J, Pérez-Martínez L, Martin K, 
Kotzamanis K, Craigon M, Auer M, 
Young NT, Walsh P, Marchant A, 
Angulo A, Forster T and Ghazal P 
(2017) Genomic Programming of 
Human Neonatal Dendritic Cells in 
Congenital Systemic and In Vitro 
Cytomegalovirus Infection Reveal 
Plastic and Robust Immune Pathway 
Biology Responses. 
Front. Immunol. 8:1146. 
doi: 10.3389/fimmu.2017.01146
genomic Programming of human 
neonatal Dendritic cells in 
congenital systemic and In Vitro 
cytomegalovirus infection reveal 
Plastic and robust immune Pathway 
Biology responses
Widad Dantoft1*†, Pablo Martínez-Vicente1,2†, James Jafali1, Lara Pérez-Martínez1,3,  
Kim Martin1,4, Konstantinos Kotzamanis1, Marie Craigon1, Manfred Auer1,5, Neil T. Young6, 
Paul Walsh7, Arnaud Marchant8, Ana Angulo2, Thorsten Forster1 and Peter Ghazal1*
1 Division of Infection and Pathway Medicine, School of Biomedical Sciences, University of Edinburgh, Edinburgh, United 
Kingdom, 2 Immunology Unit, Department of Biomedical Sciences, Medical School, University of Barcelona, Barcelona, 
Spain, 3 Quantitative Proteomics, Institute of Molecular Biology, Mainz, Germany, 4 Synexa Life Sciences, Cape Town, South 
Africa, 5 SynthSys-Centre for Synthetic and Systems Biology, School of Engineering, University of Edinburgh, Edinburgh, 
United Kingdom, 6 Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United 
Kingdom, 7 NSilico Life Science and Department of Computing, Institute of Technology, Cork, Ireland, 8 Institute for Medical 
Immunology, Université Libre de Bruxelles, Charleroi, Belgium
Neonates and especially premature infants are highly susceptible to infection but still 
can have a remarkable resilience that is poorly understood. The view that neonates have 
an incomplete or deficient immune system is changing. Human neonatal studies are 
challenging, and elucidating host protective responses and underlying cognate pathway 
biology, in the context of viral infection in early life, remains to be fully explored. In both 
resource rich and poor settings, human cytomegalovirus (HCMV) is the most common 
cause of congenital infection. By using unbiased systems analyses of transcriptomic 
resources for HCMV neonatal infection, we find the systemic response of a preterm 
congenital HCMV infection, involves a focused IFN regulatory response associated with 
dendritic cells. Further analysis of transcriptional-programming of neonatal dendritic cells 
in response to HCMV infection in culture revealed an early dominant IFN-chemokine reg-
ulatory subnetworks, and at later times the plasticity of pathways implicated in cell-cycle 
control and lipid metabolism. Further, we identify previously unknown suppressed net-
works associated with infection, including a select group of GPCRs. Functional siRNA 
viral growth screen targeting 516-GPCRs and subsequent validation identified novel 
GPCR-dependent antiviral (ADORA1) and proviral (GPR146, RGS16, PTAFR, SCTR, 
GPR84, GPR85, NMUR2, FZ10, RDS, CCL17, and SORT1) roles. By contrast a gene 
family cluster of protocadherins is significantly differentially induced in neonatal cells, 
suggestive of possible immunomodulatory roles. Unexpectedly, programming responses 
of adult and neonatal dendritic cells, upon HCMV infection, demonstrated comparable 
quantitative and qualitative responses showing that functionally, neonatal dendritic cell 
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are not overly compromised. However, a delay in responses of neonatal cells for IFN 
subnetworks in comparison with adult-derived cells are notable, suggestive of subtle 
plasticity differences. These findings support a set-point control mechanism rather than 
immaturity for explaining not only neonatal susceptibility but also resilience to infection. 
In summary, our findings show that neonatal HCMV infection leads to a highly plastic and 
functional robust programming of dendritic cells in vivo and in vitro. In comparison with 
adults, a minimal number of subtle quantitative and temporal differences may contribute 
to variability in host susceptibility and resilience, in a context dependent manner.
Keywords: infection, virus, immunity, systems biology, transcriptomics, set-point, congenital abnormalities, 
homeostasis
inTrODUcTiOn
Infection remains a leading cause of sickness and death in early 
life. While there has been extensive work investigating bacterial 
infections, viral infections are far less studied. Although diag-
nosing bacterial sepsis is highly problematic, viral infections 
are more often atypical and present an even greater challenge 
notwithstanding fewer treatment options in the newborn 
period. Host control of viral infections requires both effective 
innate and adaptive immune responses. In an indirect way, it 
can be considered that certain viral infection outcomes can be 
useful as a pan marker for both innate and adaptive immune 
health. A natural candidate example of an opportunistic viral-
marker for human immune health is Human Cytomegalovirus 
(HCMV), the most common human viral infection acquired 
in utero. In this context, key features of HCMV that make it a 
paradigmatic biomarker of immune health include ubiquity as 
a human pathogen, and especially for early life where HCMV 
is a leading member of the ToRCH complex of perinatal infec-
tions. However, most critically, infection of immune-intact 
individuals results in benign asymptomatic infection while in 
an immune compromised setting HCMV rapidly becomes a 
major clinical complication.
Symptomatic congenital HCMV causes multi-system dis-
eases that may present with intrauterine growth retardation, 
hepatosplenomegaly, cholestasis, rash, thrombocytopenia and 
intracranial and ophthalmological abnormalities, and hear-
ing loss (1, 2). Although HCMV infections can be effectively 
acquired in utero only a small percentage of newborns from 
primary maternal infections (~1–10%) will develop congenital 
disease (1). Notably, it has been recently argued that maternal 
immune responses to HCMV, against existing dogma, have poor 
predictive value to protection against congenital disease sever-
ity (3). However, the possible role of fetal immune responses 
are not considered as they are historically and presently viewed 
as redundant to maternal protection. Furthermore, the virus 
can also be efficiently transmitted to the neonate at parturition 
from contact with vaginal secretions or subsequently at the 
point of breast milk feeding. However, these neonatal infec-
tions, inclusive of premature infected infants, usually result 
in little or no clinical illness (4). A corollary from all these 
observations is that while there is an important clinical risk to 
HCMV infection in early life, in utero as well as for premature 
and full-term neonates, there is a level of resilience that is, 
de facto, an intrinsic functional marker of the underlying 
neonatal immunity.
The above viewpoint on the unappreciated resilience of 
immune health in early life raises questions about the defen-
sibility of the long accepted view that neonates (especially 
preterm) simply have increased susceptibility to infection due 
to an immature immune system that is not yet functionally 
intact and which is inherently immune deficient. The immune 
maturity/deficiency argument has also been increasingly chal-
lenged in animal neonatal model studies of infection (5–7). 
More recent human studies of neonatal sepsis and infection 
(8, 9) and human fetal innate immunity (10) are beginning to 
point toward a regulatory mechanism [reviewed in Ref. (7, 11)]. 
Examples of regulatory mechanisms encompass the concept 
of layered immunity during fetal development (12) and more 
recently to the notion of an altered set-point, through negative 
feedback, in innate immune triggering of stimulatory immune 
check-point control pathways, rather than developmental 
immune deficiency during the neonatal period (9, 11). In 
this regard, myeloid dendritic cells represent a central innate 
immune cell governing an early reference level for set-point 
control, acting as both a measuring element and an effector. In 
response to viral infections these cells rapidly produce type I 
interferon (IFN) and other inflammatory mediators, playing a 
key role for driving protective adaptive immunity.
In this report, we have sought to computationally investigate 
rare existing data resources for determining signal host pathway 
biology responses underpinning neonatal HCMV infections 
We ask whether the neonatal pathway biology, at the host sys-
temic and infected cell level, provide a test for the robustness 
of early-life immunity and whether new insights toward host 
susceptibility and resilience can be gleaned. The selected studies 
include a previous transcriptional profiling study of whole blood 
samples of “well” or infected neonates (samples taken at time of 
first clinical presentation in neonatal intensive care unit), com-
prising mainly bacterial confirmed infections with a few case 
examples of confirmed viral infection inclusive of symptomatic 
congenital HCMV (9). While it has been well established that 
there is systemically high levels of circulating IFN in congenital 
HCMV infection (13), to date, the Smith et al. (9) study provides 
FigUre 1 | Activated expression of dendritic and natural killer (NK) cell markers upon congenital neonatal human cytomegalovirus (HCMV) infection. The expression of 
immune cell markers for monocytes, neutrophils, dendritic cell, B cell, T cells, and NK cells was investigated using transcriptomic analysis of whole blood isolated from a 
congenitally HCMV-infected neonate (n = 1, red) and uninfected neonatal controls (n = 35, blue). Using Wilcoxon Rank Sum test, adjusting for false discovery, a significantly 
activated expression profile was observed for dendritic cell (p < 1.3e−15) and NK/NCT cell (p < 1.8e−08) markers, but not for markers for monocytes, neutrophils, B, 
T cells. A p-value < 0.05 was considered significant, with *p < 0.05, **p < 0.01, and ***p < 0.001 (a). The expression of immune cell markers for dendritic cells and NK/
NCT cells in uninfected controls (n = 35, blue), one HCMV-infected neonate (n = 1, red) as in (a), and 13 coagulase negative Staphylococcus-infected neonates (n = 13, 
red). Median expression is depicted as a black horizontal line and p-values < 0.05 were considered significant, with *p < 0.05, **p < 0.01, and ***p < 0.001 (B).
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the only known available data for evaluating a systemic pathway 
response presented in congenital HCMV infection and which has 
previously not been investigated. For the purpose of exploring 
the neonatal cellular response to HCMV infection, we further 
investigated a unique study by Renneson et al. (14) that previ-
ously reported on immune profiling of adult and cord-blood 
myeloid-derived dendritic cells (DCs) upon HCMV infection. 
Those studies involved transcriptomic profiling of DCs derived 
from neonatal cord-blood and adult blood in response to 
HCMV infection. However, the central conclusions drawn in 
the previous published work were primarily based from ELISA 
assay data for the differential IL-12 and type I IFN responses 
(14). While these specific differences in the immunomodulatory 
cytokine response to HCMV infection between neonatal cord-
blood cells and adult blood cells have been highlighted, global 
systematic unbiased genomic pathway biology analyses have yet 
to be reported.
Here, we investigate the hypothesis that neonates mount highly 
flexible and robust host pathway response to HCMV infection.
resUlTs
case investigation of systemic cell 
immune response to congenital hcMV 
infection
To investigate the systemic cellular responses in neonates 
up on HCMV infection, the expression of monocyte, neutrophil, 
dendritic, B, T, and natural killer (NK)/NCT cell markers were 
analyzed in transcriptomic data, derived from neonatal blood 
obtained at the first clinical signs of a suspected infection, for 
a subsequently confirmed congenitally HCMV-infected female 
preterm infant (37 weeks gestational age). For comparison 13 
preterm sepsis cases (5 females and 8 males from 27–39 weeks 
gestational age) with subsequently positive blood culture test 
result for causal Staphylococcus infection (clinical assessment 
for neonatal bacterial sepsis performed by two clinicians) (9). 
For these investigations of expression differences between the 
infected patient sample and the index control population (35 
individual samples), the array data for each sample was z-score 
transformed prior to further analysis. For the HCMV-infected 
case (Inf-075) the distribution of markers for each individual 
subset of immune cells: monocytes (n =  211 markers), neu-
trophils (n = 164 markers), dendritic cells (n = 44 markers), 
B cells (n = 144 markers), T cells (n = 225 markers), and NK 
and non-conventional T cells (n = 59 markers) (co-inhibitory, 
co-stimulatory) was compared to the distribution in uninfected 
control samples using Wilcoxon Rank Sum tests (adjusted 
for false discovery) (Figure  1A; Table S2 in Supplementary 
Material). While changes in the distribution profile of markers 
for monocytes, neutrophils, B, and T cells are not observed, sig-
nificant changes are detected for dendritic cells (p < 1.3e−15, 
adjusted) and for NK/NCT cells (p < 1.8e−08, adjusted).
To evaluate the global effects of congenital HCMV infection 
on the systemic host response, biological network relationship 
analysis was performed on the 114 genes with highest differ-
ential expression (fold change ≥3). Network analysis revealed 
the presence of two interconnected subnetworks comprising 
FigUre 2 | Differentially expressed genes upon congenital neonatal human cytomegalovirus (HCMV) infection form distinct subnetworks. STRING Network analysis 
was performed on the 114 genes with the highest significant differential expression (absolute log2FC ≥ 1.58, adjusted p < 0.05) upon congenital neonatal HCMV 
infection (Inf-075). Network analysis reveals the presence of two interconnected subnetworks comprising erythrocyte-specific genes (erythrocyte network), cell 
metabolic genes, and cell-cycle genes (cell cycle), as well as a distinct and separate subnetwork of IFN-induced genes with antiviral activity (IFN response).
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erythrocyte-specific genes (erythrocyte network) that may 
be confounded by development, and cell metabolic genes and 
cell-cycle genes (cell cycle), as well as a distinct subnetwork 
(IFN response) composed of IFN-induced genes involved in 
antiviral host responses, apoptosis, and the formation of the 
NLRP3 inflammasome that promotes the maturation of the 
inflammatory cytokines IL1β and IL18 (15) (Figure 2).
It is important to note that these findings are limited to the 
profile of congenital cytomegalovirus disease of an individual 
patient response and will require larger population studies to 
draw any general conclusions. However, computational path-
way statistical approaches can be used to explore this case in 
comparison with controls and clearly highlights, in the case 
of patient Inf-075 congenital cytomegalovirus infection, a key 
role for myeloid dendritic, but not monocyte or neutrophil 
cells, and a dominant association with a systemic IFN antiviral 
subnetwork response. Further, we note that in comparison with 
healthy controls, elevated distribution levels of NK/NCT  cell 
markers are also present in the systemic response of congenital 
HCMV. These responses are in marked contrast to individual 
bacterial (Staphylococcus) infection responses, which show no 
significant alteration in the distribution of dendritic cell mark-
ers in any of the cases examined, in contrast showing a slight 
trend toward an overall suppression, in particular, for patients 
Inf-089, 116, and 162, respectively (Figure  1B). Notably, the 
selective increase density distribution for NK/NCT cell markers 
in the HCMV case is in contrast to their significant suppression 
in the staphylococcal infection cases (Figure  1B), highlight-
ing the flexibility of the innate immune systemic response in 
neonates.
iFn responses are Dominant early 
signatures of hcMV infection of cord  
and adult Dcs Followed, at late Times,  
by a limited Differential lipid Metabolic 
Pathway response
The DCs not only act as key innate immune set-point control 
cells for triggering the adaptive arm but are also targets of viral 
infection. This further motivated us to investigate the pathway 
biology response of neonatal dendritic cells to HCMV challenge. 
For this purpose, we proceeded to investigate transcriptomic data 
(Human U 133 Plus 2.0 genome array) of infected monocyte-
derived dendritic cells (DCs) from neonatal cord-blood over time, 
previously reported by Renneson et al (14). Here, neonatal (cord) 
and adult-derived monocyte-derived dendritic cells (DCs) were 
either mock treated or infected with HCMV and RNA harvested 
for genome-wide array analysis at 6 and 16 h postinfection. After 
normalization and filtering of the 54,676 gene probes, hybridized 
with labeled DCs RNA on the Human U 133 Plus 2.0 genome 
array platform, 1,862 probes were considered significantly differ-
entially expressed from mock-infected controls with an absolute 
expression value of log2FC ≥ 1, and an adjusted p-value < 0.05 
after false discovery correction.
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After 6 h postinfection, 272 genes were significantly differen-
tially expressed in cord DCs (compared to mock-infected DCs), 
exhibiting a strongly activated profile (Figure 3A). Out of these, 
222 were significantly upregulated and 50 genes significantly 
downregulated, a greater number than previously reported. Note 
that this difference depends on the chosen parameters for analy-
sis (data pre-processing algorithms, non-specific filtering, type of 
test and multiple-testing adjustment used, as well as level of fold 
change considered). For comparative purposes, 6 h post HCMV 
infection of adult DCs, 316 genes are significantly differentially 
expressed, exhibiting a strongly activated profile that is highly 
similar to that of infected cord DC. Out of these 316 genes, 221 
were significantly upregulated and 95 genes were significantly 
downregulated.
Figure 3A further shows that at 16 h post HCMV infection, 
a greater number of differentially regulated genes are further 
detected in adult and cord DCs. In the case of cord DCs, an 
increased number of 1,474 genes were significantly expressed, 
with 1,124 genes upregulated and 350 genes downregulated. 
A similar number of differentially expressed genes were observed 
in adult DC (1,402), out of which 1,031 genes were upregulated 
and 371 were downregulated.
In HCMV-infected cord DCs, consistent with Renneson et al., 
an over representation of immune system pathways was observed 
among the upregulated genes (14), with a focus on cytokine 
signaling and type I IFN response (IFNA1 and IFNB1, IFN 
signaling pathway) mediated by the RIG/MDA5 signaling activa-
tion as well as type III IFNs (Figure  3B). Many IFN-induced/
stimulated genes with reported antiviral activity, including IFI6, 
IFI35, IFIT1, IFIT2, IFIT3, IRF7, ISG15, and ISG20, were found 
to be significantly upregulated after 6 h of infection, as well as an 
induced expression of various type I IFNs (Table 1), cytokines 
(Table 2), and chemokines (Table 3). Phenotypically the overall 
cytokine response has a hallmark for a strongly activated pro-
inflammatory response. We further note that apart from IRF7, no 
other interferon regulatory factors (IRFs) were detected. Notable, 
interferon response factor 2 binding protein 2 (IRF2BP2) that 
in an IRF2-dependent manner functions as a transcriptional 
co-repressor was downregulated. Strikingly, these responses are 
mirrored in the 6 h post infected adult DCs.
The number of upregulated genes in these pathways increased 
with the progression of infection (from 6 to 16 h of infection) for 
both neonates and adults (Figure 3B, right panel), suggesting that 
an increased innate immune function dominates a large portion 
of the activated profile observed at 16 h of infection (Figure 3A). 
In addition to an increased number of activated genes involved in 
immune system processes, genes involved in maintaining the cell 
cycle were observed at 16 h of infection and the overall robustness 
of response is similar between neonate and adult (Figure  3B). 
This outcome was not expected and is suggestive of plasticity 
between neonatal and adult DCs responses.
Notably, TLR7, previously shown to recognize single-stranded 
RNA from HIV, HCV, and HCMV in other systems (16–18), 
was the only TLR gene found to be upregulated in the infected 
cord-derived DCs. With an initially unchanged expression at 
6 h of infection, its expression was significantly upregulated at 
16 h of infection, suggesting a delayed enhancement of this TLR 
gene during infection. TLR4, TLR6, and TLR8 all demonstrated 
a downregulated expression in infected cord DCs. In this con-
nection, Smith et al. showed an upregulation of TLR4, 5, 7, and 8 
in HCMV-infected macrophages, while TLR1, TLR2, TLR3, and 
TLR5 were unchanged (17). Genes categorized as belonging to 
immune system pathways (including TLR6, IFNGR1, and FOS) 
as well as TLR cascades (CD36, CTSB, FOS, JUN, TLR4, TLR6, 
and TLR8), with reported partial immunoregulatory roles, 
were also present among the downregulated genes (Figure 3C). 
Notably, CD36, a multifunctional glycoprotein, has been shown 
to function as a co-receptor for the TLR4:TLR6 heterodimer, 
promoting inflammation in monocytes/macrophages (19).
As the infection progressed, an increased number of downregu-
lated genes was also similarly detected for neonatal and adult cells, 
with the exception of genes associated with the glycerophospholipid 
biosynthesis pathway that is exclusively observed at early times for 
cord infected cells (Figure 3C). There is a notable shift from a mod-
est number of genes at the 6 h time point categorized as belonging 
to the sphingolipid de novo biosynthesis pathway (2 in cord and 
adult cells, respectively) and metabolism of lipid and lipoprotein 
(3 and 6 in cord and adult, respectively), to a clear increase in the 
number of downregulated genes (23 and 27 in cord and adult, 
respectively) involved in metabolism of lipids and lipoproteins 
(including genes involved in sphingolipid de novo biosynthesis and 
triglyceride biosynthesis) (Figure 3C; Table 4). Moreover, the two 
over-represented pathways nucleotine-like (purinergic) receptors 
and signaling by NOTCH1, at 6 h of infection, are not significantly 
over-represented at 16  h. Instead a small number of genes are 
grouped as belonging to neurophilin interactions with VEGF and 
VEGFR are overrepresented at 16 h. Unlike lipid metabolism, the 
expression of genes involved in glycolysis/gluconeogenesis and 
the citrate cycle (TCA) were moderately changed at 6 and 16 h of 
infection (Tables 5 and 7). In particular, only a few glycolytic/glu-
canogenic genes exhibited an infection-induced change in expres-
sion (PGM2L1, LDHAL6B, ENO3, ALDH8A1, and ALDH18A1). 
While LDHAL6B was initially upregulated at 6 h of infection, its 
expression was undetectable later in the infection (16 h). PGM2L1, 
ALDH8A1, and ALDHL18A1 on the other hand all displayed a 
delayed response and were only significantly upregulated by 16 h of 
infection, while ENO3 exhibited a downregulated response at 16 h.
The number of downregulated genes involved in metabolism 
and transport of lipids and lipoproteins increased from 4 [glycerol-
3-phosphate dehydrogenase 1 (GPD1), PLPP3 (PPAP2B), PNPLA3, 
and VAPA] at 6 h to 22 genes at 16 h (ABCA1, ABCC3, ACOX2, 
ACSL5, AKR1C3, ALOX5, CD36, CYP1B1, CYP27A1, CYP27B1, 
FABP4, GPAT3, GPD1, PIK3CG, PLA2G5, PNPLA3, PLPP3, 
PPARG, PPM1L, PRKACB, TBXAS1, and VAPA). Further investi-
gation of genes involved in metabolism of lipids and lipoproteins 
revealed an activation of ASAH2, CROT, CYP1A1, CYP2U1, 
CYP7B1, ELOVL4, ELOVL6, ELOVL7, INSIG1, LCLAT1, LDLR, 
MED30, PEX11A, PIK3C2A, PIK3R3, PIP5K1B, PLA2G12A, 
PLA2G4C, PTGS2, RORA, SEC24A, SGMS2, SLC27A2, and 
SPTLC2 at 6 or 16 h of infection (Table 4).
Further sub-categorization using REACTOME (20, 21) rev-
ealed pathways for triglyceride biosynthesis (ACSL5, GPAT3, and 
GPD1) and sphingolipid de novo biosynthesis (PLPP3, PPM1L, 
and VAPA) (Tables 5 and 6). However, further analysis revealed 
FigUre 3 | HCMV-infected cord-derived DCs display an activated antiviral pathway response dominated by IFN-induced cytokine signaling, increased cell-cycle activation, 
and a suppression of lipid metabolism. Volcano plots showing the genome-wide expression profile in cord and adult-derived DCs upon 6 and 16 h of HCMV infection (a). 
Graphs visualizing the over-represented pathways (ORA), and the number of significantly expressed genes grouped within each ORA, present among the significantly 
upregulated genes (B) and significantly downregulated genes (c) at 6 and 16 h postinfection in cord (black bars) and adult (gray bars) DCs (B,c). The genes grouped in 
Immune system and Metabolism of lipid and lipoproteins are further sub-categorized into several immune system and lipid metabolism-related pathways. Pathways not 
identified in one of the two datasets (but present in the other), or pathways with non-significant corrected p-values (p > 0.05), are marked with “ns”.
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TaBle 3 | Fold-change expression of chemokine genes in HCMV-infected cord 
and adult DCs.
systematic 
name
common 
name
cord 6 h cord 16 h adult 6 h adult 16 h
CCL1 I-309 nd nd nd nd
CCL2 MCP-1 9.18 6.67 5.62 3.28
CCL3 MIP-1α nd nd nd nd
CCL4 MIP-1β 9.96 5.58 3.74 nd
CCL5 RANTES 4.69 19.80 7.78 27.86
CCL7 MCP-3 4.59 12.11 5.55 7.54
CCL8 MCP-2 33.73 54.62 43.33 60.70
CCL11 Eotaxin nd nd nd nd
CCL13 BCA-1 nd nd nd nd
CCL17 TARC nd nd nd nd
CCL19 ELC nd 2.14 nd nd
CCL20 MIP-3α 4.83 8.92 nd 6.51
CCL21 SLC nd nd nd nd
CCL22 MDC nd nd nd nd
CCL23 MIP3 nd nd nd nd
CCL25 TECK nd nd nd nd
CCL27 DTACK nd nd nd nd
CCL28 MEC nd 2.00 nd nd
CX3CL1 Fractaline/
neurotactin
nd nd nd nd
CXCL1 GRO-α nd nd nd nd
CXCL2 GRO-β nd nd nd nd
CXCL3 GRO-γ nd nd nd nd
CXCL5 ENA78 nd nd nd nd
CXCL6 GCP-2 nd nd nd nd
CXCL7 NAP-2 nd nd nd nd
CXCL8 IL8 5.52 2.65 4.39 nd
CXCL9 MIG 10.18 90.94 23.80 75.06
CXCL10 IP-10 280.55 438.22 216.16 288.74
CXCL11 I-TAC 286.21 1,113.54 253.76 691.84
CXCL12 SDF-1 nd nd nd nd
CXCL13 BCA-1 nd nd nd nd
CXCL14 BRAK nd nd nd nd
CXCL16 – nd nd nd nd
XCL1 Lymphotactin nd nd nd nd
nd, not detected.
TaBle 2 | Fold-change expression of cytokine genes in HCMV-infected cord 
and adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h
IL1A 2.76 nd nd −2.59
IL1B 7.06 2.14 3.46 nd
IL2 nd nd nd nd
IL3 nd nd nd nd
IL4 nd nd nd nd
IL5 nd nd nd nd
IL6 nd nd nd nd
IL7 3.10 3.15 4.02 2.55
IL9 nd nd nd nd
IL10 nd nd nd nd
IL11 nd nd nd nd
IL12B nd nd nd nd
IL13 nd nd nd nd
IL15 2.75 nd 6.16 2.26
IL16 −2.63 −5.75 −2.78 −7.96
IL17A nd nd nd nd
IL18 nd nd nd nd
IL24 nd nd nd nd
IL27 nd nd nd nd
IL32 nd nd nd nd
IL33 nd nd nd nd
nd, not detected.
TaBle 1 | Fold-change expression of interferon genes in HCMV-infected cord 
and adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h
IFNA1 17.88 271.56 37.32 366.51
IFNA2 nd 11.96 nd 12.65
IFNA4 nd 11.55 nd 32.99
IFNA5 nd 8.71 nd 12.13
IFNA6 nd nd nd nd
IFNA7 nd 6.33 nd 12.08
IFNA8 nd 27.34 nd 44.33
IFNA10 nd 2.91 nd 4.09
IFNA13 nd 19.01 4.56 33.32
IFNA14 nd 10.53 nd 18.06
IFNA16 nd 11.35 nd 22.92
IFNA21 nd 3.51 nd 4.75
IFNB1 18.44 9.12 50.34 20.44
IFNE nd nd nd nd
IFNG nd nd nd 9.53
IFNL1 (IL29) nd nd nd nd
IFNL2 (IL28A) nd nd nd nd
IFNW1 nd 4.44 nd 5.00
nd, not detected.
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activation of several other pathway members; including ELOVL4, 
ELOVL6, ELOVL7, and LCLAT1 for triglyceride biosynthesis 
(Table  5), and INSIG1, LDLR, CD36, and CYP27A1 for the 
sterol metabolic network (Table  4), SGMS2 and SPTLC2 for 
sphingolipid de novo biosynthesis, respectively (Table 6). While 
ELOVL7 was activated already at 6 h of infection, both ELOVL4 
and ELOVL6 displayed a delayed response (activated at 16 h of 
infection). Elongation of very long-chain fatty acids (ELOVL) 4, 
6, and 7 are membrane bound proteins that all catalyze the first 
rate-limiting step in the elongation of very long fatty acids (FAs) 
(22–24), required for the biosynthesis of lipids, sphingolipids, and 
eicosanoids.
HCMV has been shown to not only extensively alter the host 
cell’s metabolism, including inducing FA metabolism (25), but 
also alter vesicle membranes. It is thus assumed that HCMV 
manipulates the host cell’s lipid metabolism to facilitate virion 
assembly and/or to use FAs as structural components. Interesting, 
ELOVL7 is known to be inducible by HCMV in infected human 
foreskin fibroblasts (26). Notably, Koyuncu et  al. (27) showed 
that inhibition of FA metabolism affects not only to the forma-
tion of new virions but also infectivity of the newly produced 
virions (27). Nevertheless, it is clear that HCMV infected host 
cells synthesize saturated very long-chain fatty acids (VLCFAs), 
which appear to be incorporated in its virion lipid membrane 
(27). Furthermore, ELOVL7 is the one of the ELOVLs associated 
with the synthesis of elongation of very long FAs (24), reveal-
ing an association between metabolism and HCMV infection. 
However, it is worth noting that these responses are also likely to 
be important for immunomodulatory functions.
TaBle 4 | Fold-change expression of genes involved in metabolism of lipids and lipoproteins in HCMV-infected cord and adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h step
ABCA1 nd −2.02 nd nd Efflux of cholesterol and phospholipids
ABCB4 nd nd nd −4.38 Phosphatidylcholine transporter
ABCC3 nd −5.96 −2.75 −7.49 Not determined
ACOX2 nd −3.96 nd −3.42 Degradation of long branched fatty acids (FA)
ACSL5 nd −3.57 nd −4.47 Converts free long-chain fatty acid (LCFA )> FA-CoA esters, FA degradation via 
beta-oxidation
AKR1C3 nd −4.71 nd −18.28 Aldehydes and ketones > corresponding alcohols
ALOX5 nd −3.41 nd −2.82 Catalyzes first step in leukotriene biosynthesis, important for inflammatory 
response
ASAH2 3.01 8.92 3.38 5.69 Ceramide > sphingosine
CD36 −2.02 −2.77 −3.67 −4.66 Binds LDL among others, supports inflammatory response
CROT nd 5.96 nd 3.66 4,8-dimethylnonanoyl-CoA > carnitine ester
CYP1A1 4.82 nd 3.80 nd Substrate unknown
CYP1B1 nd −2.95 nd −5.44 Estradiol > 4-OH-estradiol or 2-OH-estradiol
CYP27A1 nd −4.71 nd −6.55 First step in the oxidation of side chains of sterol intermediates
CYP27B1 nd −4.12 −2.53 −4.02 25(OH)D3 > 1,25-(OH)2D3 (Calcitrol)
CYP2U1 nd 7.99 nd 7.06 LCFA > biologically active epoxides
CYP7B1 nd 4.10 nd 3.01 25-HC > 7-alpha,25-OHC
ELOVL4 nd 9.67 nd 7.96 CnCOOH > Cn + 2COOH (n > 16)
ELOVL6 nd 2.96 nd 2.58 CnCOOH > Cn + 2COOH (n > 16)
ELOVL7 2.20 5.93 nd 6.62 CnCOOH > Cn + 2COOH (n > 16)
FABP4 nd −3.69 nd −4.97 Lipid transport protein
G0S2 nd nd nd −5.68 Inhibits the rate-limiting lipolytic enzyme ATGL
GPAT3 nd −5.81 nd −17.02 Lysophosphatic acid (LPA) > phosphatic acid (PA)
glycerol-3-phosphate 
dehydrogenase 1
−2.72 −3.81 nd −3.26 Dihydroxyacetone phosphate + NADH > glycerol-3-P + NAD+
INSIG1 8.44 nd 4.65 nd Inhibits SREBP activation, binds SCAP and HMG-CoA
LCLAT1 nd 5.55 nd 5.81 LPA > PA
LDLR 4.41 nd nd −2.29 Binds cholesterol-carrying LDL, promotes endocytosis
ME1 nd nd nd −3.59 Generates NADPH for FA biosynthesis
MED30 nd 4.02 nd 3.42 May play a role in cardiovascular disease
PEX11A nd 2.50 nd 3.10 Promotes membrane protrusion and elongation on the peroxisomal surface
PIK3C2A nd 2.05 nd nd Functions in clathrin-coated endocytic vesicle formation and distribution
PIK3CG nd −3.14 nd −6.06 PtdIns(4,5)P2 > PIP3, immune activator
PIK3R3 nd 4.67 2.67 4.10 PtdIns > PIP
PIP5K1B nd 4.39 nd 6.03 Participates in the biosynthesis of phosphatidylinositol 4,5-bisphosphate
PLA2G12A nd 4.25 nd 4.12 Membrane phospholipids > Free FAs + lysophospholipids
PLA2G4C nd 3.84 nd nd Hydrolyzes phospholipids > FA + other lipophilic molecules
PLA2G5 nd −3.96 nd nd Membrane phospholipids > FFA + lysophospholipids
PNPLA3 −2.04 −5.01 −3.05 −5.49 Mediates triacylglycerol hydrolysis
PLPP3 −2.52 −5.68 −3.05 −7.62 PA > DG
PPARG nd −5.59 nd −9.54 Forms dimer with RXR to activate gene expression
PPM1L nd −2.38 nd −2.78 Dephosphorylates MAP3K7 and MAP3K5
PRKAA2 nd nd nd 2.42 Catalytic subunit of AMPK
PRKACB nd −3.49 nd −4.38 cAMP dependent PKA subunit
PTGS2 22.61 21.47 19.45 14.24 Arachidonate > prostaglandin H2
RORA nd 22.20 nd 17.10 Mediates cell binding, signaling, and cytoskeletal organization
SEC24A nd 2.91 nd 2.01 Component of COPII-coated vesicle
SGMS2 2.15 5.24 nd 3.32 Ceramide >< sphingomyelin
SLC27A2 nd 6.63 nd 7.53 LCFA > fatty acyl-CoA esters
SPTLC2 2.72 3.63 3.76 3.24 l-serine + palmitoyl-CoA > 3-oxo-sphinganine
SQLE nd nd nd −2.19 Squalene > 2,3-oxidosqualene
TBXAS1 nd −4.58 nd −5.38 Prostaglandin H2 > thromboxane A2
UGCG nd nd nd nd 1-ceramide > 4GLCβ1
VAPA −2.28 −3.10 −3.27 −4.53 Binds OSBPL3, stimulates RRAS signaling
nd, not detected; >, conversion.
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Conversely, LCLAT1, which converts lysophosphatic acid (LPA) 
to phosphatic acid (PA), remained unchanged from mock-infected 
cells during early infection but was subsequently upregulated as the 
need for lipids increased. This is possibly required for the main-
tenance of the cell expansion, as indicated by the upregulation of 
genes involved in cell division and cycle progression (Figure 3B) 
and may represent a viral high-jacking of lipid metabolism to build 
virions. Intriguingly, the expression of GPAT3 that encodes an 
enzyme that also converts LPA to PA, remained unchanged at 6 h 
but are subsequently downregulated as the infection proceeded, 
TaBle 6 | Fold-change expression of genes involved in sphingolipid de novo 
biosynthesis in HCMV-infected cord and adult DCs.
gene cord  
6 h
cord 
16 h
adult 
6 h
adult 
16 h
step
PPLP3 nd −2.38 nd −2.78 Phosphatic 
acid > Diacylglycerol
PPM1L 2.15 5.24 nd 3.32 Dephosphorylates MAP3K7 
and MAP3K5
SGMS2 2.72 3.63 3.76 3.24 Ceramide >< sphingomyelin
SPTLC2 −2.28 −3.10 −3.27 −4.53 l-serine + palmitoyl-
CoA > 3-oxo-sphinganine
VAPA nd −2.38 nd −2.78 Binds OSBPL3, stimulates 
RRAS signaling
nd, not detected, >, conversion.
TaBle 5 | Fold-change expression of genes involved in triglyceride biosynthesis in HCMV-infected cord and adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h step
ACSL5 nd −3.57 nd −4.47 FAs > Acyl-CoA
ELOVL4 nd 9.67 nd 7.96 CnCOOH > Cn + 2COOH (n > 16)
ELOVL6 nd 2.96 nd 2.58 CnCOOH > Cn + 2COOH (n > 16)
ELOVL7 2.20 5.93 nd 6.62 CnCOOH > Cn + 2COOH (n > 16)
GPAT3 nd −5.81 nd −17.02 LPA > PA
glycerol-3-phosphate dehydrogenase 1 −2.72 −3.81 nd −3.26 Dihydroxyacetone-P > glycerol-3-P
LCLAT1 nd 5.55 nd 5.81 Lysophosphatic acid > PA
nd, not detected, >, conversion.
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displaying an opposing expression pattern from LCLAT1 during 
late infection. GPD1, encoding GPD1 was downregulated in cord 
DCs already from 6 h of infection and stayed downregulated as 
the infection proceeded, while in adults it remained unchanged 
until 16 h, at which it was downregulated. GDP1 has been shown 
to convert dihydroxyacetone phosphate and NADH, from the 
glycolysis pathway, to glycerol-3-P and NAD+, which feeds into 
triglyceride biosynthesis (28). Finally, ACSL5 encoding ACSL5, 
which converts long-chain fatty acids to fatty acyl-CoA esters, was 
downregulated in the HCMV-infected DCs.
Taken together, these results suggest that the initial antiviral 
innate immune response, to HCMV infection in cord-blood and 
adult peripheral derived DCs, is dominated by a strong IFN and pro-
inflammatory cytokine signaling, and chemokine receptor binding, 
centered on the activation of ISG15 (Figure 3). As the infection pro-
gresses, a heightened innate immune gene activation and increased 
cell-cycle activation and metabolic changes are observed. Overall, 
there is a striking similarity of the responses between neonatal and 
adult-derived DCs to HCMV infection, with only minor quantita-
tive and qualitative differences exhibited. These results strongly 
suggest that neonatal dendritic cells have the capacity to produce a 
robust and flexible innate immune response to viral infection.
neonatal Molecular Pathways Develop 
robust Pro-inflammatory subnetwork 
responses Upon infection
To further corroborate and explore the response to HCMV infec-
tion of DC we undertook an integrative STRING and InnateDB 
analysis to define subnetworks of genes regulated in the course of 
HCMV infection of neonatal cord (Figure 4) and adult (Figure 5) 
derived DCs.
STRING network analysis of the neonatal upregulated genes 
revealed, at 6 and 16 h, the formation of distinct subnetworks of 
IFN-responsive genes (IFN cluster, cIFN6-16h) and chemokines 
(chemokine cluster) that as the infection proceeded increased 
in complexity (Figure 4A; Table S1 in Supplementary Material). 
At 6 h of infection, the IFN repertoire was limited to IFNA1 and 
IFNB1 but at 16 h it had increased sevenfold in number (IFNA1, 
IFNA2, IFNA4, IFNA5, IFNA7, IFNA8, IFNA10, IFNA13, 
IFNA14, IFNA16, IFNA21, IFNB1, and IFNW1) (Table  1). 
Conversely, the expression of IFNAR1 and IFNGR1 was either 
unchanged by infection or downregulated with time, respectively, 
indicative of plasticity in regulating the type I IFN response and 
a disengagement of the type II IFN response. Moreover, two 
IFN-stimulated genes (ISGs), ISG15, and ISG20, as well as genes 
involved in ISG15 antiviral mechanism (DDX58, IFIT1, EIF2AK2, 
MX1, MX2, HERC5, and STAT1) were found be induced in the 
infected cord DCs at both time points after infection, indicating 
a strict regulation of cellular antiviral responses with counter 
balance through the induction of USP18 for both neonatal cord 
and adult cells (Table S1 in Supplementary Material).
Interleukin gene activation was limited to IL1A, IL1B, IL7, 
and IL15 at 6  h, followed by a downregulated expression of 
all genes, except IL7, at 16  h of infection. Pro-inflammatory 
chemokine expression of CCL2, CCL4, CCL5, CCL7, CCL8, 
CCL19, CCL20, CCL28, CXCL8, CXCL9, CXCL10, and CXCL11 
all exhibited an activated expression profile. By contrast IL16, a 
chemoattractant and modulator of T cell activation (29, 30), was 
downregulated at both 6 and 16 h of infection. Furthermore, for 
both neonates and adults a downregulation of pro-inflammatory 
genes (CSF1R, LRRK2, and MAF) (31–33), and genes involved 
in promoting lymphocyte activation and signaling, such as 
BLC6, GNAQ, SLA, and SYK was observed (34–40) (Figures 4B 
and 5B). This suggests that the while a strong IFN response is 
induced in DCs, an attempt at restricting the immune response 
is made by suppressing key genes promoting the inflammatory 
activation of lymphocyte activation and signaling. Together the 
dual play between inflammatory activation and negative feed-
back highlight the underlying flexibility in the immunomodula-
tory response.
The repertoire of IFN antiviral response gene subnetworks, 
included, but was not limited to, MX1, MX2, OAS2 and OAS3, 
OASL, IFIT1-3, IFIT5, IF16, IFI35, GBP1 and 2, and IFITM1-3 
TaBle 7 | Fold-change expression of genes involved in glycolysis/glucanogenic in HCMV-infected cord and adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h step
ALDH18A1 nd 6.36 nd 9.26 Glutamate > glutamate 5-semialdehyde
ALDH8A1 nd 2.87 nd 3.96 9-cis-retinal > 9-cis-retinoic acid
ENO3 nd −2.45 nd nd 2-phosphglycerate > phosphoenolpyrovate
LDHAL6B 4.54 nd 4.82 nd Paralog of LDHAL6A
PGM2L1 nd 3.50 nd 2.57 Synthesizes glucose-1,6-bisphosphate and glucose-1,5-bisphosphate
nd, not detected; >, conversion.
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FigUre 4 | Continued
(41–47). Notably, USP18 has a key role for potently inhibiting 
the IFN response maintaining a cellular balance of ISG15-
conjugated proteins by cleaving ISG15 fusions (48). Other 
notable antiviral responsive pathways include TRIM5 and 
TRIM6 that are also associated with Cell network (see below). 
TRIM5 and TRIM6, two E3-ubiquitin ligases, have been shown 
to play a role in retroviral restriction. TRIM5 has been shown 
to promote premature disassembly of the viral capsid (CA) 
protein lattice blocking reverse transcription, nuclear entry, 
and integration (49), delivering the restriction-sensitive retro-
viral capsids to autophagosomes for destruction (50, 51), and 
promoting TAK1-dependent innate immune signaling (52) 
FigUre 4 | Differentially expressed genes in HCMV-infected cord DCs form distinct subnetworks. STRING Network analysis of up- and downregulated genes  
in cord DCs, form at 6 and 16 h of infection distinct subnetworks (a,B). Among the upregulated genes, after both 6 and 16 h of infection, two immune-related 
subnetworks are identified [IFN cluster (cIFN6-16h) and chemokine cluster] and at 16 h, specifically, a network of cell-cycle-related genes (cell-cycle network) and  
a network of fatty acid (FA) metabolism genes (FA metabolism) are identified (a). Among the downregulated genes several G-protein coupled genes (encircled) are 
identified at 16 h of infection (B). The identified members of each network can be found in Table S1 in Supplementary Material.
11
Dantoft et al. Cytomegalovirus: Marker of Neonatal Immune Health
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1146
suggesting that TRIM5 acts as an innate immune pattern recog-
nition receptor (PRR) specific for the capsid lattice. Similar to 
TRIM5, TRIM6 have been shown to display antiviral properties 
by stimulating IKBKE-mediated antiviral responses including 
induction of IFN-β (acting downstream of MAVS/IPS-1) and 
ISGs (including IRF7 and ISG15), but not NF-κB-dependent 
cytokines (53).
Distinctively, one large cell-cycle network, comprising of clus-
tered gene encoding proteins involved in chromatin remodeling 
during mitosis and DNA replication and cell-cycle progression, 
was identified among the upregulated genes (Figure 4A; Table S1 
in Supplementary Material). These included, but were not limited 
to, the genes identified in the pathway analysis (Figures  3B). 
Moreover, a small network of genes involved in FA metabolism 
(ELOVL6, ELOVL7, and PTGS2), was also identified.
Notably several networked (encircled) and disconnected 
(not shown) G-protein coupled proteins were identified among 
the downregulated genes (Figure  4B; Table  9), including 
genes encoding proteins involved in the complement system 
(C5AR1) (54), inflammatory response (ADORA3, ARRB1, and 
CXCR4), and GRK3 (ADRBK2), and RGS18 that function as a 
beta-adreneric receptor kinase, a receptor for ADP, a receptor 
for succinate, and as a regulator of G-protein signaling, respec-
tively. Interestingly, ADORA3 has previously been reported to 
be involved in the regulation of dendritic cell phagocytosis and 
inflammatory response (55). Glucocorticoid dexamethasone-
differentiation of monocyte-derived human DCs was shown 
to upregulate ADORA3 (and other apoptophagocytic genes) 
resulting in enhanced capacity of dendritic cells to engulf 
apoptotic neutrophils and to induce an inflammatory response 
(55). Moreover, beta-arrestin 1 (ARRB1) has been shown to be 
involved in IL8-mediated granule release in neutrophils (56) and 
to regulate IL8-induced CXCR1 internalization in HEK 293 cells 
(57). The signaling by the chemokine receptor, CXCR4, has been 
shown to be enhanced by the US27 gene of HCMV product (58). 
Furthermore, HCMV-encoded UL33 and UL78 have been shown 
to heteromerize with CXCR4, affecting cell surface expression, 
internalization, and activity (59).
Overall, the network analysis of up- and downregulated genes 
in adult DCs revealed, among the upregulated genes, similar 
networks as those observed in the cord DCs (IFN cluster cIFN6-
16h, Cell-cycle network and FA metabolism) consistent with 
identified over-represented pathways (Figure  3), suggesting a 
concordance in the cellular response between HCMV-infected 
cord and adult DCs (Figure 5A). Moreover, similar to cord DCs 
the same networked and disconnected (not shown) G-protein 
coupled receptors were also identified in the networked down-
regulated genes at 16  h of infection (Figure  5B). Interestingly, 
many of the identified GPCRs have been shown to regulate B 
and T lymphocyte activation and modulate the Th1/Th2 balance 
(60–65), suggesting that the downregulation may be associated 
with limiting viral spread as well as the inflammatory response.
Altogether, these results suggest that HCMV infection in 
neonatal and adult DCs strongly induce dynamic plastic changes, 
FigUre 5 | Differentially expressed genes in HCMV-infected adult DCs form distinct subnetworks similar to those in neonatal cord DCs. STRING Network analysis 
of up- and downregulated genes in adult DCs, form at 6 and 16 h of infection distinct subnetworks (a,B). Among the upregulated genes, after both 6 and 16 h of 
infection, two immune-related subnetworks are identified [IFN cluster (cIFN6-16h) and chemokine cluster] and at 16 h a network, specifically, of cell-cycle-related 
genes (cell-cycle network) and network of fatty acid (FA) metabolism genes (FA metabolism) are identified (a). Among the downregulated genes several G-protein 
coupled genes (encircled) are identified at 16 h of infection (B). The identified members of each network can be found in Table S1 in Supplementary Material.
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that affecting cellular gene networks functionally involved in pro-
inflammatory antiviral host immune response as well as immune 
cell expansion.
loss-of-Function screen identifies Pro- 
and antiviral roles for the suppression of 
gPcr network upon infection
As described above a notable suppression of GPCRs are 
found at late times of infection in both neonates and adults. 
Macrophages and dendritic cells are well known to express a wide 
range of GPCRs that influence their immune function (66–70). 
Indeed wide ranges of inflammatory mediators are known to 
couple to GPCRs, including ATP (71), histamine (72), LPA (73), 
and sphingosine-1-phosphate (74). By contrast, little is known 
about anti or proviral functions of GPCRs. Network analysis of 
the differentially expressed genes in cord DCs, revealed among 
the downregulated genes after 16 h of HCMV infection several 
GPCRs with pro-inflammatory response function (ADORA3, 
ARRB1, C5AR1, CXCR4, GPR34, GPR183, GRK3, and RGS18) 
(Figure  4B; Table  9). In addition to these, HCMV infection 
of cord DCs resulted in a suppression of several other GPCRs 
[including GPR68, GPR183 (EBI2), and GPR146] that, together 
with C5AR1, CXCR4, and RGS18, have been shown to be 
highly enriched in unstimulated macrophages and dendritic 
cells (67, 69, 70, 75) (Table  9). Among the GPCRs that were 
found to be upregulated (CCL2, RGS5, RGS20, GNAI1, GNG11, 
GPR27, GPR37, GPR161, GPR180, and HCAR3) only CCL2, 
RGS5, RGS20, and GNG11 have been shown to be expressed in 
macrophages and dendritic cells and/or implicated in immunity 
(70, 76–79). HCAR3 expression has, however, been shown to 
be induced in breast cancer patient samples, where it plays a 
role in controlling intracellular lipid/FA metabolism (80). At 6 h 
of infection, the expression of most, but not all, of the identi-
fied GPCRs remained unchanged from mock-infected cells 
(Figure  4B; Table  9). The expression of ARRB1 and GPR146 
were both slightly downregulated whereas the expression of 
GPR34 was downregulated eightfold and the expression of 
HCAR3 and RGS20 upregulated fivefold.
The most highly downregulated GPCR in the HCMV-infected 
cord DCs were regulator of G protein signaling 18 (RGS18) and 
G-protein coupled receptor 34 (GPR34), which have been shown 
to be significantly expressed in DCs (70, 75). In addition to 
RGS18 and GPR34, the expression of ADORA3, ARRB1, C5AR1, 
CXCR4, GPR68, GPR82, GPR146, GPR183 (EBI2), and GRK3 
(ADRBK2) was also highly suppressed at 16 h. The same GPCRs 
identified in cord DCs, with exception for GNG11 and HCAR3 
(not differentially expressed), were also found to be differentially 
expressed in adult DCs after viral infection, with some already 
repressed after 6 h of infection, many unchanged, and CCL2 and 
RGS20 upregulated fivefold to sixfold (Figure 5B; Table 9). As 
infection progressed in the adult-derived DCs, similar expres-
sion changes as those observed in cord DCs were observed for 
all GPCR genes, but GNG11 and HCAR3 that did not exhibit 
an altered gene expression. Together, these results suggest that 
while the overall GPCR regulation is seemingly similar between 
cord and adult DCs, subtle differences, that possibly fine tune 
the activity of the DC response, exist.
To further investigate the role of these receptors in HCMV 
infection, the role of GPCRs on viral replication and spread 
was functionally investigated. An unbiased Human GPCR 
SMARTpool RNAi library screen was performed using HCMV-
GFP infected MRC-5 human fetal lung fibroblasts (Figure 6). 
The siRNA library screen consisted of pools of siRNA (4 siRNA 
duplexes that each target a single cellular gene) targeting a total 
of 516 individual GPCRs. Screens (n = 6) were conducted in 
three separate independent biological replicate screening assays 
in order to stringently identify a reproducible high confidence 
hit. The siRNA-mediated knockdown identified 117 GPCRs that 
when depleted resulted in a significantly reduced viral replica-
tion. Rank-product analysis of the multiple independent GPCR 
SMARTpool screen statistically identified 11 high confidence 
GPCR hits (RGS16, SCTR, PTAFR, GPR84, GPR85, NMUR2, 
FZD10, RDS, CCL17, SORT1, and GPR146), whose loss of expres-
sion resulted in the strongest negative effects on HCMV replica-
tion (p-value < 0.05) and one hit (ADORA1) for antiviral role. 
While siRNA-mediated knockdown of all 12 hits did not affect 
cell viability under the conditions tested (Figure 6A; Table 8), 
further siRNA deconvolution experiments, validating the hits 
of the library screen identified CCL17, GPR84, GPR85, PRAFR, 
RGS16, and SORT1 as particularly noteworthy. We find in high 
content image analysis that siRNA-mediated knockdown results 
in a visually marked reduced replication and spread of HCMV 
at late time points of infection (70 and 94 h postinfection) that 
is independent of cell viability (Figures 6B,C). Out of the 117 
candidate genes in the screen, only CCL2, GPR82, and GPR146 
were found to be differentially expressed in the HCMV-infected 
cord and adult DCs.
regulatory Pathways for Modulating the 
iFn immune response are a central 
Feature Developed in hcMV-infected 
neonatal and adult Dcs
A repeating pathway biology theme in the host response to 
infection is that immune activation pathways are concurrent 
with immune inhibitory. This counter balance readily estab-
lishes feedback networks leading to flexibility and plasticity 
in response for ensuring host protection but which can also 
provide an unwanted opportunity to the virus. In this regard 
the observed activation of genes involved in ISG15 antiviral 
mechanism and RIG/MDA5-mediated induction of IFNα/β 
pathways (Figures  3–5; Table S1 in Supplementary Material) 
results prompted us to further investigate the regulation of these 
immune response by studying the expression profile of various 
inhibitors/regulators of the immune response and their targets 
(Figure 7). For these studies activators and inhibitors of PRRs 
and IFN receptors and their downstream signaling pathways 
were investigated. Furthermore, the expression of inhibitors of 
IFN production, as well as the expression of TRIMs and TRIPs 
that have been shown to regulate the immune response, was 
also investigated. Known immune inhibitors such as SMAD6 
FigUre 6 | Loss-of-function screen of GPCRs using an HCMV real time replication assay. MRC-5 fibroblasts were reverse-transfected (n = 3 with two technical 
replicates) with siRNA from the Human GPCR SMARTpool library followed by infection with AD169-GFP HCMV. Untreated controls cells, mock treated cells (reagent 
only), siRNA targeting eGFP, HSV ICP5, HSV VP11/12, HSV VP16, HVEM, Non-Targeting Pool, and cells treated with RISC-free siRNA served as negative controls. 
Cells treated with siRNA, against IE2 and UL54 served as positive controls. All cells were infected with AD169-GFP HCMV post-siRNA treatment and growth 
monitored using eGFP detection. Distribution profile of (plate-by-plate negative control-normalized) virus replication slopes across the entire screen 
[median ± median absolute deviation (MAD)], indicating controls and potential hits of interest (a). High-content images (PerkinElmer OPERA) of siRNA-treated and 
AD169-GFP-infected fibroblasts at two different time points (B,c). Knockdown of PTAFR or RGS16 was followed by infection with AD169-GFP HCMV for 70 h  
(B) and 94 h (c). Untreated controls cells, mock treated cells (reagent only), and cells treated with RISC-free siRNA, all infected with AD169-GFP HCMV, served as 
negative controls. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI) and actin was visualized with AlexaFluor-647-Phalloidin.
14
Dantoft et al. Cytomegalovirus: Marker of Neonatal Immune Health
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1146
that inhibits TGF-beta anti-inflammatory signaling, PTPN22, 
a phosphatase repressor of IFNG activation of myeloid cells, 
RAB7B as a moderator (through lysosome degradation mecha-
nisms) of TLR-IFN responses in human dendritic, and to some 
extent SQSTM1 with roles in autophagy and IFNG host defense, 
were all actively expressed in mock-infected cells, but their 
expression is repressed upon infection (Figure  7B). TRIM59 
also maintained a repressed state throughout early infection, 
followed by a strong activation at 16  h of infection. SOCS1, 
encoding Suppressor of cytokine signaling 1, which is induced 
by STAT1 activation in response to cytokine stimulation, was 
induced early in infection (6 h), followed by an active down-
regulation from 6 to 16  h of infection. Furthermore, PTGS2 
involved in the production of anti-inflammatory prostaglandins 
was also induced upon infection, with possible negative roles 
upstream and downstream of blocking IFN-STAT1-IRF acti-
vation pathways, while IRF2BP2 a potent repressor of innate 
inflammation was not (Figure 7B).
In addition, several genes encoding inhibitors of DDX58/
RIG-I (IFI35, DHX58, ISG15) and IRF7 (GBP4, OASL 
TaBle 8 | Rank-product analysis of GPCR SMARTpool screen results indicating 
putative hits with the strongest negative effect on HCMV replication (percentage 
of false positives, pfp < 0.05).
symbol pfp 
value
Median 
neg-norm 
virus 
replication
Median 
neg-
norm cell 
viability
no. of deconvoluted 
sirnas that reduce virus 
repl. (median + median 
absolute deviation) 
by ≥ 45% compared to 
controls
RGS16 0.001 0.08 1.225 3/4
SCTR 0.008 0.16 0.977 2/4
PTAFR 0.009 0.20 1.422 3/4
GPR84 0.009 0.23 1.038 4/4
GPR85 0.015 0.26 0.958 3/4
NMUR2 0.018 0.27 1.072 2/4
FZD10 0.018 0.24 1.366 2/4
RDS 0.020 0.29 0.680 2/4
CCL17 0.021 0.29 1.086 3/4
SORT1 0.022 0.26 0.907 3/4
GPR146 0.039 0.35 1.345 2/4
TaBle 9 | Fold-change expression of GPCR genes in HCMV-infected cord and 
adult DCs.
gene cord 6 h cord 16 h adult 6 h adult 16 h in gPcr 
sMarTpool 
screen
ADORA3 nd −9.49 nd −4.78
ARRB1 −2.20 −3.49 −2.76 −5.11
C5AR1 nd −2.75 nd −6.14
CCL2 9.18 6.67 5.62 3.28 *
CXCR4 nd −7.83 −3.52 −9.93
GNAI1 nd 12.94 nd 9.38
GNG11 nd 4.77 nd nd
GPR27 nd 4.04 nd 4.14
GPR34 −7.91 −22.40 −5.69 −13.49
GPR37 nd 12.41 nd 9.32
GPR68 nd −2.04 nd −3.29
GPR82 nd −3.39 nd −4.63 *
GPR146 −2.02 −3.27 −2.12 −3.29 *
GPR161 nd 3.37 nd 3.98
GPR180 nd 2.98 nd 2.69
GPR183 nd −7.88 nd −7.60
GPSM2 nd 4.69 nd 3.74
GRK3 nd −6.47 nd −7.26
HCAR3 5.60 nd nd nd
LANCL1 nd 4.92 nd 4.24
P2RY13 nd nd nd nd
RGS18 nd −12.58 −12.75
RGS20 5.62 2.99 5.88 nd
RGS5 nd 3.21 nd 3.30
S1PR1 nd nd nd nd
SUCNR1 nd nd nd nd
nd, not detected; >, conversion.
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and TRIM21) are also upregulated in infected cord DCs 
(Figures  7A,B) (81–83). Meanwhile, the expression of both 
DDX58 and IRF7, the master transcription factor for type I 
IFN, were upregulated at both 6 and 16 h of infection. Activated 
DDX58 has been shown to interact and dimerize with both MAVS 
and MDA5 (84), resulting in the activation of TBK1 and IKBKE 
(IKKE) followed by the subsequent phosphorylation-induced 
activation of IRF3 and IRF7 and transcriptional activation of 
antiviral genes including IFNA and IFNB. IFI35 was recently 
identified in a genome-wide small siRNA screen as an IFN-
induced protein required for vesicular stomatitis virus infection 
(81). Overexpression of IFI35 was demonstrated to suppress the 
IFNB and IFIT promoters. Furthermore, IFI35 was also shown 
to inhibit activation of DDX58 (inhibit dephosphorylation of 
DDX58) and to regulate proteasome-mediated degradation of 
DDX58 (81), overall, implicating IFI35 in negatively regulating 
type I IFN signaling in a DDX58-dependent manner. DHX58, 
also known as LGP2, has on the other hand been shown to 
both positively and negatively regulate DDX58 and MDA5-
mediated antiviral signaling (85–87). Similar to IFI35 and 
ISG15, it showed a consistent infection-induced transcriptional 
response. Its inhibitory action on DDX58 signaling may involve 
competition with DDX58 for binding to (1) the viral RNA 
(88), (2) binding to DDX58 and, thus, preventing dimerization 
between DDX58 and MAVS (82), or (3) competing with IKBKE 
(IKKE) for its binding to MAVS, subsequently inhibiting 
activation of IRF3 (89). Finally, ISG15 encodes an ubiquitin-
like protein that has been shown to exhibit antiviral activity 
toward several viruses including Influenza A, HIV-1, and Ebola 
virus (90–92). It conjugates (ISGylation) to intracellular target 
proteins upon activation by IFNα and IFNβ (83, 91, 93–98). 
In addition to DDX58, ISG15 has been shown to target MX1 
and EIF2AK2 (83), which were modified (upregulated) in the 
infected DCs. Notably, ISG15, is a target of USP18, a type I 
IFN-induced ubiquitin specific protease that effectively cleaves 
specifically ISG15 fusions (Figure  7). In the HCMV-infected 
cord and DCs, USP18 was also upregulated. USP18-deficient 
mice have been shown to demonstrate a large increase in 
ISG15-conjugates (99) as well as a hypersensitivity to IFN, link-
ing USP18, as well as ISG15, to negative regulation of the type 
I IFN response (100). GBP4, OASL, and TRIM21, which have 
been shown to posttranslationally modify the activation and 
function of IRF7 (101–104), all displayed an infection-induced 
expression (Figure 7B).
Guanylate-binding protein 4, GBP4, has been identified as 
a negative regulator of the virus-induced type I IFN response, 
by disrupting TRAF6-mediated IRF7 ubiquitination (101). Of 
note, the expression of both TRAF3 and TRAF6 were unaffected 
by the infection (expressed below the threshold of detection). 
TRIM21, which was upregulated by the infection, encodes an 
E3-ubiquitin ligase that has been shown to, upon interaction 
with FADD, ubiquitinate IRF7 (103). Ubiquitination of IRF7 
was shown to affect the phosphorylation status of IRF7 and its 
interaction with TRAF6, resulting in a repressed IFNα expres-
sion in Sendai-infected cells (103). TRIM21 has, furthermore, 
been shown to regulate the type I IFN signaling pathways in 
human microglial cells infected with Japanese encephalitic 
virus, which induces an innate immune response by increasing 
the production of IFNβ via IRF3 activation and phosphoryla-
tion (105). Finally, human 2′-5′-Oligoandenylate Synthase Like 
(OASL), on the other hand, has been shown to exhibit antiviral 
activity by enhancing specifically DDX58 signaling by mim-
icking polyubiquitin (104), distinguishing it from the murine 
OASL1 protein that negatively regulates type I IFN upon viral 
FigUre 7 | Expression analysis of immune activators and inhibitors reveal a complex regulation of the IFN response, centered on DDX58 and IRF7 activation.  
The immune inhibitors and immune activators that were identified among the significantly differentially expressed genes, in HCMV-infected cord and adult-derived 
DCs, and the relationship between them, is depicted in (a). Their per-gene normalized expression in mock-infected (0 h), 6 h, and 16 h postinfection is visualized 
using hierarchical clustering (B).
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infection by inhibiting the translation of IRF7 mRNA (102). 
Loss of OASL expression has been shown to reduce DDX58 
signaling and enhanced viral replication.
In addition to genes encoding negative immune modula-
tors several genes encoding immune activators [fibroblast 
growth factor receptor 3 (FGFR3), JUN, STAT1, and TAB 3] 
and co-stimulators/inhibitors (DDX58 and IRF7) were likewise 
differentially expressed in the infected cord and adult DCs. In 
addition to DDX58 and IRF7, the expression of STAT1, regulated 
through positive feedback by IRF7 (106), was also activated and 
maintained throughout the infection. Notably, JUN was acti-
vated in mock-infected cells and maintained throughout early 
infection (6 h), but repressed as the infection progressed (16 h). 
Concurrently, FGFR3 and TAB 3 maintained a repressed state 
until late infection (16 h) (Figure 7B). While a direct immuno-
logical role for FGFR3 has not yet been described, this tyrosine-
protein kinase has been shown to play an essential role in the 
regulation of cell proliferation differentiation, and apoptosis. 
Moreover, SOCS1 and SOCS3 (not detected) have been shown 
to interact and modulate FGFR3 signaling in chondrocytes 
(107), blocking MAPK cascade signaling. Furthermore, FGFR3 
activation of the MAPK cascade, albeit in the context of multi-
ple myeloma, has been shown to block the promoter function, 
expression, and secretion of the chemokine CCL3 (108), linking 
both SOCS1 and FGFR3 to the modulation of the chemokine 
response.
The concurrent regulation of activators and inhibitors of the 
DCs likely represent both host and viral driven responses and are 
especially reflective for a tunable level of flexibility in develop-
ing a plastic response to HCMV infection that can be robustly 
regulated upwards or downwards.
strong concordant Pathway Biology 
responses to infection Predominate  
over a Minimal subtle Difference in 
Programming between neonatal and  
adult Dcs
The above analyses show, rather than the anticipated strong 
hyporesponsive mode of neonatal DCs to infection, a strong and 
FigUre 8 | Continued  
Cord and adult DCs show a high concordant genome-wide response to 
HCMV infection but differential expression of clustered and non-clustered 
PCDH genes late upon HCMV. PCA clustering over time of mean whole-
genome gene expression (log2 mean expression) in mock-infected and 
HCMV-infected neonatal cord (red) and adult (blue) DCs (a). Regression 
analysis of mean whole-genome gene expression (log2 mean expression), 
between cord and adult DCs, show a strong correlation in mock (R = 0.95) 
and at 6 h (R = 0.96) and 16 h (R = 0.96) of infection (B). Volcano plots 
comparing log2 mean expression values of filtered genes between adults and 
cord DCs, after false discovery correction (−log10 FDR) (c). Fold-change 
expression levels of PCDH genes in cord (red bars) and adult DCs (blue bars) 
16 h of HCMV infection, relative to mock-infected cord and adult DCs (set as 
1) (D). The error bars indicate the SEM. Statistical significance was calculated 
using non-paired student t-test. *p < 0.05, **p < 0.01, and ***p < 0.001.
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robust activation of host protective and immunomodulatory 
functions. This raises the question of how similar or different 
the overall quantitative and qualitative responses are between 
cord and adult-derived DCs. To quantitatively investigate the 
similarities and dissimilarities in the response between cord and 
adult DCs, we first applied a principal components analysis for 
all samples tested. Figure 8A clearly shows that samples closely 
grouped with regard to time of infection and not by cord or 
adult origin. This outcome is consistent with the pathway inves-
tigations described above in HCMV-infected cord and adult 
DCs suggestive of concordant pathways alterations, involving a 
similar number of genes within each over-represented pathway. 
Most strikingly and not fully anticipated we further find an 
extremely high correlation exceeding R  =  0.95 between the 
programme of gene expression between neonates and adults 
cells at each point of infection (mock, 6 and 16 h postinfection, 
respectively) (Figure 8B). Hence, we conclude that there exists 
a high similarity in the immune response against HCMV infec-
tion in both neonates and adults.
Notably, the high correlation between neonatal and adult 
mock-uninfected DCs points to an almost identical molecular 
phenotype. Accordingly, we next proceeded to test directly 
for any statistically significant differentially expressed genes 
using an empirical bayes test adjusted for false discovery. 
We find only 33 genes with an adjusted p < 0.05 and twofold 
change in gene expression between mock-uninfected adult and 
cord DCs (Figure  8C, mock panel, Table S4 in Supplementary 
Material). These genes do not form any defined network or 
pathway; however, at the gene analytic level there are few dif-
ferentially expressed genes worth commenting. Specifically, the 
basal expression levels of RSAD2, one of the most strongly type 
I IFN inducible genes, is significantly higher in adult DCs. This 
might suggest a resting level that could be reflective in adult 
DCs for a possible primed or increased tonic state in com-
parison with cord DCs, although this represents the only IFN 
inducible gene identified. There are also two anti-inflammatory 
associated genes, PLA2G5 and DDIT4L, which are more highly 
expressed in the neonatal DCs. These data suggest that if there is 
an elevated anti-inflammatory state, in cord DC in comparison 
with adult-derived cells, it is extremely subtle and very weak 
but plausibly could have an impact upon the speed of immune FigUre 8 | Continued
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activation. Consistent with this notion, the pathway biology 
analysis identified a potent IFN response with altered kinetics 
in adults and cord-derived cells for a broad expression pattern 
of type IFN genes (Figures 3–5; Table 1). Similar to cord DCs 
that expressed a modest number of type I IFN genes (IFNA1 and 
IFNB1) at 6 h, the expression of IFN genes in adult DCs was also 
restricted to type I IFN genes (IFNA1, IFNA13, and IFNB1). At 
16 h of infection, the IFN repertoire in adult DCs increased both 
in numbers of genes and in expression strength (IFNA1, IFNA2, 
IFNA4, IFNA5, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, 
IFNA16, IFNA21, IFNB1, IFNG, and IFNW1), consistent with 
the observations in cord DCs. While gene induction in adult 
DCs was higher than in cord DCs, broadly the same genes are 
induced in both cell types late in infection, with exception that 
in adult DCs a statistically significant increase in IFNG is seen. 
Notably, for both cord and adult DCs, expression of IFNB1 was 
initially induced at 6 h followed by a marked repression, while 
IFNA1 was the strongest induced gene in both adults and cord 
DCs at late times.
At 6 and 16 h postinfection a comparison between infected 
cord and adult-derived populations showed a slight increase in 
statistically significant differentially expressed genes accounting 
for 46 and 43 genes, respectively (Figure 8C). Again these genes 
lists (Table S4 in Supplementary Material) do not represent any 
selective pathway or network; however, at the gene analytic level 
there is a far greater percentage of significant genes activated in 
the cord cells. At 6 h postinfection a number of markers that 
have the capacity to contribute an anti-inflammatory role are 
expressed at a slightly higher level in the neonatal cord cells 
in comparison with adults, and include CD200, ALOX5, and 
CHI3L1. These markers may highlight a very subtle elevation in 
negative feedback with potential impact in altering the reference 
level of the set-point for triggering the adaptive immune arm in 
neonatal cord cells. At 16 h the multifaceted Chitinase-3-like-1 
protein (CHI3L1) marker remains elevated in neonatal cells. 
However and most strikingly, 12 members of the multigene pro-
tocadherin (PCDH) family were highly upregulated 16 h post 
HCMV infection in cord DCs (Figure 8D). PCDHs comprise 
a large group of transmembrane proteins within the cadherin 
superfamily. Cadherins are calcium-dependent adhesion 
glycoproteins involved in the regulation of cell–cell contacts 
(109). The PCDHs include >80 molecules, expressed mainly 
in the vertebrate nervous system, that play several important 
roles in the development of the brain, in the organization and 
formation of neural circuits, and in the regulation of brain func-
tion and dendritic development (110–112). Also, it is reported 
that some PCDHs may act as tumor suppressors, inhibiting the 
proliferation and metastasis of cancer cells (113, 114). Both 
PCDH8 and PCDH9, two non-clustered PCDHs, were found to 
be upregulated in the HCMV-infected DCs. PCDH8 has been 
shown to be involved in synaptic plasticity of dendritic cells and 
represents a linkage to schizophrenia (115, 116). The PCDH9 
is also related with a neurological disease and autism spectrum 
disorder (117). Both PCDH8 and PCDH9 have, furthermore, 
been shown to be mutated or downregulated in a variety of 
tumors (118–120).
In addition to the non-clustered PCDH8 and PCDH9 genes, 
several clustered PCDH genes were upregulated after 16  h of 
infection (Figure 8D). To date most PCDH studies are related to 
neurological functions (121–125). Remarkably, the combinato-
rial expression patterns of the clustered PCDHs can generate 
enormous cell surface diversity, with 3 × 1010 variations for each 
individual neuron. This type of diversity on DCs may impart 
immune modulatory interactions. Taken together, this suggests 
that the PCDH genes, upregulated in HCMV-infected cord 
DCs, could play an important role in yet to be defined immune 
cell–cell interactions and possibly the clinical neurological 
diseases that can appear during the congenital infection.
Overall we conclude that neonatal derived cells are relatively 
unrestricted and imbued with a full plastic capacity to be 
programmed in a similar manner to adult-derived cells upon 
infection. However, this response is not completely identical 
and a very small number of gene-specific significant differences 
are apparent. Further, while statistically not significant, after 
relaxing false discovery correction, type I IFN gene networks 
are found to be temporally and quantitatively differentially 
expressed between cord and adult cells. This highlights a rather 
subtle difference in negative feedback that may have a role in 
governing the reference level of the set-point for DCs effector 
functions. Nevertheless, these results clearly highlight that neo-
natal DCs have the full capacity to mount robust effector host 
pathway response as adult DCs.
DiscUssiOn
Here, we highlight that HCMV is an excellent marker of human 
immune health developing benign infections for those with a 
healthy immune system but presents with devastating conse-
quences for an immune compromised patient. The developing 
fetus and neonates are an especially vulnerable population with 
HCMV remaining a leading cause of congenital infection. 
The overall birth prevalence of congenital HCMV infection is 
approximately 0.5% but with the majority (90%) of these infec-
tions developing no major sequelae. Accordingly, this points to an 
underlying resilience in immune health for this highly susceptible 
population that is poorly understood and which is inconsistent 
with existing dogma about the immune mechanisms governing 
early-life immunity.
We find through a case investigation of the systemic response 
of a congenitally infected preterm infant a highly robust myeloid 
and non-conventional T  cell response showing anticipated 
strong type I IFN antiviral response. Of the myeloid cells the 
dendritic cells show a significant change. While our present 
investigations are limited to a single case, further infected cases 
will need to be studied before any general conclusions can be 
drawn. Nevertheless, it is well known that DC play a critical 
role in sensing and driving immune responses to viral infec-
tions. Indeed, there is good evidence linking DC Type I IFN 
response to regulate the adaptive T and B cell with the accepted 
view that neonatal DCs and other innate immune cells respond 
sub-optimally to infection via differential TLR stimulation 
(126–128). Many of these studies use gene or protein analytic 
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investigations and only limited work applying a more global 
system level investigation [e.g., (129)] has been presented. 
Nevertheless, to date the consensus view is that neonatal cells 
have a propensity to develop a hypo-inflammatory state, that 
impact on lymphoid cells as well as the possible involvement of 
myeloid-derived suppressor cells (130–132).
In our investigation of neonatal cord and adult DCs for 
genome-wide molecular pathway biology responses we strik-
ingly find a very similar overall vigorous response between 
neonatal and adult-derived DCs, with only minor and selec-
tive temporal differences revealed in gene expression changes 
upon HCMV infection. While these findings warrant further 
investigations to increase statistical power to draw general 
conclusions, a very recent study (10) examining fetal and adult 
DC populations (through flow cytometry and transcriptomics) 
found R > 0.92 correlation of gene expression profiles compar-
ing different adult and fetal DC populations. Furthermore, 
functional activation assays showed comparable behavior 
between fetal and adult DCs, suggesting that fetal DCs are capa-
ble of mediating a strong innate immune response. However, in 
those studies fetal DCs but not adult DCs were found to express 
higher levels of ARG2 that had a regulatory impact on T cell 
activation; a finding consistent with the set-point hypothesis 
described in more detail below. In the case of the neonatal and 
adult DCs infected with HCMV, both significantly induced 
ARG2 to comparable levels. Notwithstanding the similarity in 
ARG2 expression we do detect very subtle and specific kinetic 
differences in IFN-responsive genes in HCMV-infected DCs 
between neonates and adults and which may differentially 
impact immune stimulatory and suppressive responses. We 
conclude from our, in vivo and in vitro, investigations of early-
life infection with HCMV leads to a strong and flexible innate 
immune response and which, on the basis of existing dogma for 
neonatal immunity, is unexpected.
signal immune-Metabolic innate Pathway 
Biology responses to hcMV infection  
in Dendritic cells
The central hallmark signature observed for both adult and 
neonatal cord DCs is type I IFN responses. The IFN responses 
represent an important protective antiviral response in dendritic 
cells. It is notable that while the magnitude of the IFN response 
is similar, inclusive of TLR gene expression; however, a kinetic 
difference is observable with a more immediate response detect-
able in adult DCs that might be suggestive of a more exquisite 
TLR stimulation capacity in adults in comparison to neonates. 
Indeed, small quantitative but specific differences in the expres-
sion of myeloid cells are known to impact on co-stimulatory and 
immune-suppressive functions (133). However, it is also note-
worthy that the overall scale, magnitude and pathway biology are 
strikingly similar between cord and adult DCs and is a strong 
mark of a plastic response.
While there is a robust pro-inflammatory innate immune 
activation equally observed with infected cord and adult DCs, 
other major pathways of note are associated with cell cycle, GPCR 
signaling and metabolic pathway alterations. Of the metabolic 
pathways major alterations are seen for pathways centered on 
lipid metabolism, in particular upregulation of sterol (in particu-
lar oxysterol metabolism) and long-chain FA synthesis. Notably 
these pathways are more prominent in adult DCs and are sug-
gestive of known proviral or immune-metabolic responses. In 
contrast a key unknown network downregulated upon infection 
is a GPCR network. To explore the functional significance of the 
GPCR network to HCMV infection we conducted an unbiased 
systematic viral infection screen of siRNA knock down of 516 
known GPCRs. Notably, while a few displayed antiviral roles 
(e.g., ADORA1) a far greater number were found to contribute 
to a proviral role, in particular GPR146, RGS16, and PTAFR. 
These targets identify new previously unknown host-dependent 
genes/pathways that provide excellent drug targets for inhibiting 
viral replication.
Myeloid Dendritic cell (Dc) inflammatory 
responses That Distinguish the set-Point 
hypothesis Mechanism from immune 
immaturity in neonates
The susceptibility to infection in early life is often assumed to be 
due to developmental immaturity of the immune system and as a 
consequence is hyporesponsive to infection leading to an overall 
insufficiency toward protection. As discussed this view has been 
primarily generated through selective analysis of a number of 
inflammatory mediators and there has been limited systematic 
investigation through unbiased global analyses. Critically, the 
immaturity mechanism fails to fully account for resilience. 
As previously mentioned, there is increasing evidence pointing to 
an alternative mechanistic understanding that we have previously 
proposed to involve a set-point control system in the regulation of 
the immune response to infection. The set-point hypothesis read-
ily accounts for both susceptibility and resilience through altering 
the reference level for triggering the adaptive immune response 
(11). In this regard, innate immune myeloid cells, in particular 
dendritic cells, play a critical role as early sensors and effectors of 
the immune response to generating the set-point reference level in 
viral infection.
Figure  9 shows a schematic summary of the temporal DC 
response to infection and the differential outputs in the context 
of the immaturity hypothesis and the set-point hypothesis, in 
neonates and adults. In the scenario of “immature” DC, the 
programmatic inflammatory response to infection is inherently 
lower (hypo-inflammatory) both in terms of kinetics of response 
and in magnitude for neonatal cells that consequently fail to trig-
ger the adaptive arm; while adult DCs produce a robust normal 
response for triggering T and B cell effectors, via immune check-
point control interactions. By contrast, in the case of the set-point 
control mechanism, the programmatic inflammatory response to 
infection in neonatal cells is expected to be similar in magnitude 
to adults but with slightly altered kinetics. This is likely generated 
through subtle and variable negative feedback, leading to a set-
point reference with a variable range from normal to high for 
triggering T and B cell responses.
FigUre 9 | Summary figure.
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The distinguishing hallmark feature between these two 
mechanisms is that the genomic programming (measurable at the 
transcriptomic level) is in the case of the immaturity hypothesis 
non-plastic while for the set-point hypothesis develops a highly 
plastic response that would be anticipated to be functionally pro-
tective and thereby aiding resilience. However, a high set-point 
reference maintained through increased negative feedback may 
also further promote an inhibitory immune check-point control 
of the adaptive arm leading to an immunosuppressive state with 
an increased susceptibility to infection and disease. In this study, 
we find clear evidence for a plastic response in infected neonatal 
DCs consistent with the set-point hypothesis model rather than 
immaturity model. Further, we also note that the set-point 
hypothesis is also consistent with a recent seminal study revealing 
in dendritic cells homeostatic immune-suppressive responses in 
fetal life during gestation but not for adult cells (10).
concluding remarks
In comparison with adults the natural history of neonatal HCMV 
infection is clearly associated with higher risk of susceptibility 
to disease yet there is a previously neglected consideration of 
resilience that, epidemiologically reveals little or no clinical 
illness. On balance this neglected aspect of resilience to HCMV 
infection in early life indicates that neonatal immune health 
has, contrary to the current dogma of immune deficiency, the 
capacity to mount a plastic protective immune response to 
infection. Here, we report, through an unbiased investigation, 
molecular evidence based on computational pathway biology of 
neonatal HCMV infection that supports rather than refutes this 
proposition. Moreover, these findings together with recent pub-
lished work add further weight toward supporting regulatory 
mechanisms consistent with an altered homeostatic set-point 
in myeloid immune stimulatory and suppressive functions 
rather than developmental immaturity. Critically, unlike the 
immaturity hypothesis, the set-point hypothesis can account 
for both susceptibility and resilience to infection.
Specifically we find in a systemic congenital infection response 
a significantly marked activation of myeloid dendritic cells as well 
as markers for NK and/or non-conventional T cells. These HCMV 
associated molecular-cellular systemic responses are in marked 
contrast to neonatal bacterial infections that show little activation of 
dendritic cells but which instead exhibit marked changes in mono-
cytes and neutrophils. Moreover we unexpectedly find that the cell 
intrinsic programming ability of neonatal and adult-derived DCs 
are similar; revealing only very subtle changes associated with the 
regulatory and temporal feedback control of immune activation. 
Overall, the in vivo and in vitro findings highlight that neonatal 
immunity is relatively intact demonstrating plasticity to mount 
effective host responses but which may result in subtle regulatory 
mechanistic differences in temporal and feedback control.
In summary, our findings are consistent with the previously 
proposed hypothesis that neonatal immunity is not overly 
impaired but may have a different homeostatic set-point in 
controlling key immune checkpoint stimulatory and inhibitory 
pathways. We believe HCMV neonatal infection provides a 
valuable clinical disease model to examine set-point control in 
neonates and to illuminate central control mechanisms of neona-
tal immunity through studying asymptomatic and symptomatic 
neonates.
MaTerials anD MeThODs
human cord Monocyte-Derived Dendritic 
cell (Dc) and human Whole Blood gene 
expression
Data for the cord and adult monocyte-derived dendritic cells (DCs) 
gene expression analysis were previously published by Renneson 
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et al. (14), and can be accessed at the Expression Omnibus (134), 
hosted by the National Centre for Biotechnology Information, 
under accession number GSE101855. All data for the human 
whole blood gene expression analysis can be accessed at the Gene 
Expression Omnibus (134) under accession number GSE25504.
statistical analysis
Data processing and analysis for transcriptomic data were 
performed with R Language and Environment for Statistical 
Computing (135).
For quality control, and data processing, Bioconductor 
packages (136) was used. Quality control and data processing 
determined one adult sample (GSM2717282) as an outlier, and 
for this reason it was excluded from further study, giving a final 
sample number for mock-infected cord (n = 3) and adult (n = 3) 
DCs, 6 h HCMV-infected cord (n = 3) and adult (n = 3) DCs, 
and 16 h HCMV-infected cord (n = 3) and adult (n = 2) DCs. 
The arrayQualityMetrics package (137) was used to determine 
data quality. Background correction and normalization was done 
using the RMA (138) algorithm. For further downstream analysis 
in R, first, a low constant (value = 1) was added to all normalized 
log2 expression values to eliminate negative values generated as an 
artifact during background correction. Next, a non-specific filter 
was applied to remove gene probes with low variance across all 
samples in the study (SD ≤ 0.4) and to further remove gene probes 
without existing transcript annotation, both in order to reduce 
the number of non-informative gene probes affecting multiple-
testing adjustment subsequent to statistical testing. To remove 
redundant gene probes (per gene), each gene was represented a 
gene probe with the maximum coefficient of variation (CV). The 
per-gene hypothesis of differential average expression was tested 
between the HCMV-infected groups and the control group, 
using the empirical Bayes moderated t-test (limma package) 
(139). Resulting p-values were adjusted for multiple testing using 
the Bonferroni–Holm algorithm (140). Genes with an absolute 
log2FC ≥ 1 and an adjusted p < 0.05 were considered statistically 
significant.
Analyses of the human neonatal study, including 1 HCMV-
infected neonatal patient sample (Inf-075, GSM627045) and 13 
Coagulase negative Staphylococcus samples [Inf084 (GSM627048), 
Inf-089 (GSM627049), Inf114 (GSM627054), Inf116 
(GSM627055), Inf119 (GSM627056), Inf125 (GSM627057), 
Inf133 (GSM627059), Inf138 (GSM627060), Inf152 
(GSM627063), Inf157 (GSM627064), Inf162 (GSM627066), 
Inf198 (GSM627069), and Inf203 (GSM627070)], were done as 
described (9). All downstream analysis of the human neonatal 
data was performed on per-sample z-score transformed values 
(mean = 0, SD = 1) for direct comparability.
Cell type enrichment analysis, visualized with distribution 
plots, was based on manually procured lists of cell type specific 
marker genes (Table S2 in Supplementary Material) and was 
performed on significantly differentially expressed probes that 
were manually procured from the z-score transformed neonatal 
array [Sample Inf-075 and all control samples (GSM627008–
GSM627042)]. The initial numbers of cell markers, for each cell 
type, were for B cells (381 genes), T cells (244 genes), dendritic 
cells (72 genes), monocytes (230 genes), neutrophils (837 genes), 
and NK cells (77 genes). The number of genes, for each cell type, 
after (a) mapping of marker lists to the neonatal array platform 
and (b) exclusion of invariate markers, resulted in a reduced num-
ber of cell markers that were subsequently used for generating the 
distribution plots. The final number of genes for each cell type 
was for B  cells (144 genes), T  cells (225 genes), dendritic cells 
(44 genes), monocytes (211 genes), neutrophils (750 genes), and 
NK/NCT cells (59 genes). Shapiro–Wilks test was used to estab-
lish if these data follow a normal distribution, informing the deci-
sion to compare collective markers for a given cell type were then 
compared between control and HCMV using non-parametric 
Wilcoxon Rank Sum tests. FDR correction using Bonferroni was 
done on p-values produced using Wilcoxon Rank Sum tests. Cell 
marker expression analysis in controls (average z-score of 35 
controls), Inf-075, and the 13 coagulase negative Staphylococcus 
samples, visualized with technical dot plots, was performed 
on the same manually procured from the z-score transformed 
neonatal arrays (see Table S2 in Supplementary Material for lists 
of cell markers), and the median was calculated.
Comparative analysis of the expression of manually procured 
genes for immune inhibitors (n = 15 genes) and activators (n = 7 
genes) (141, 142), investigated using per-gene normalized hierar-
chical clustering, was done on the HCMV-infected cord DCs (6 
and 16 h) and mock-infected DCs controls.
For comparative analysis of genome-wide response to HCMV 
infection in mock-infected and HCMV-infected cord and adult 
DCs, cord and adult samples were normalized and filtered 
together. A filter of CV > 0.1 (CV of a gene across all samples 
was required to be > 10%) was applied. Regression analysis was 
applied to assess the correlation of fold-change values between 
cold and adult samples.
network and Pathway analysis
Computational network-based approaches were used to examine 
the relationships in the data using correlation of gene expression 
and biological relationships. InnateDB1 (143–145) and STRING2 
(146) were used to examine biological network relationships and 
association with known pathways [REACTOME (20, 21)] among 
differentially expressed genes (absolute log2FC  ≥  1, adjusted 
p < 0.05) in infected cord DCs at 6 and 16 h of infection. STRING 
analysis of the 114 top differentially expressed genes (absolute 
log2FC >  1.58, adjusted p <  0.05), upon congenital neonatal 
infection, was performed on z-score transformed values from 
patient arrays GSM627045 (114 genes). To examine biological 
network relationships in STRING, “experiments,” “co-expres-
sion,” and “databases” were chosen as active interaction sources, 
and a minimum required interaction score of 0.400 (medium 
confidence) was used for all analysis. Identified members within 
subnetworks, and their fold-change expression, are listed in 
Table S1 in Supplementary Material. Pathway analyses were car-
ried out step-wise using a pathway biology approach, becoming 
more focused. Back-transformed fold changes for differentially 
1 http://www.innatedb.com 
2 http://www.string-db.org 
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expressed immune effector genes and metabolic genes (absolute 
log2FC ≥ 1, adjusted p < 0.05) are presented in Tables 1–9.
Mrc-5 human Fibroblasts
MRC-5 human lung fibroblasts (ATCC® ATCC-CCL-171™) 
were maintained in EMEM (Lonza AG, Basel, Switzerland) 
supplemented with 10% Fetal Calf Serum (Lonza AG), 2  mM 
l-glutamine (Lonza AG), MEM Non-Essential Amino Acids 
(Lonza AG), and 50 U/ml penicillin/streptomycin (Lonza AG). 
Cells were transferred to DMEM (Lonza AG) supplemented with 
10% Fetal calf serum (Lonza AG), 2  mM l-glutamine (Lonza 
AG), and MEM non-essential amino acids (Lonza AG) (hence-
forth referred to as complete DMEM media), at least 24 h prior 
to reverse transfection, and used by passage 33.
sirna
The Human GPCR SMARTpool library (GE Dharmacon, 
Lafayette, CO, USA; Cat#G-003600; Lot#050915) consists 
of mixtures (pools) of four siRNA duplexes each targeting a 
single cellular gene (see Table S3 in Supplementary Material 
for list of genes targeted). To validate the results of the original 
SMARTpool screen, the following deconvoluted SMARTpools 
(i.e., sets of four individual siRNA duplexes corresponding to the 
original SMARTpools) were ordered for following targets (GE 
Dharmacon): ADORA1 (MU-005415-03), CCL17 (MU-007828-
01), FZD10 (MU-005500-01), GPR146 (MU-005549-01), 
GPR84 (MU-005604-00), GPR85 (MU-005605-01), NMUR2 
(MU-005671-00), PTAFR (MU-005709-00), RDS (MU-011102-
01), RGS16 (MU-008386-01), SCTR (MU-005724-03), SORT1 
(MU-010620-01). Deconvoluted SMARTpools were first 
screened as individual duplexes (3 biological replicates with 2 
technical replicates/biological replicate) to validate the results of 
the original SMARTpool screen, and then sets of four duplexes 
were combined in equal proportions to form “reconstituted 
SMARTpools” for further validation experiments. siRNA controls 
used were as follows (GE Dharmacon; catalog numbers or custom 
sequence as indicated): eGFP (P-002102-01-20), IE2 (ggaagaa-
cagggugaagaauu), UL54 (cgauagaacaugagaggcauu), HVEM 
(M-008096-00), Non-Targeting siRNA Pool #1 (D-001206-13-
20), RISC-Free (D-001220-01-20), ICP4 (gcggcgacgacgacgauaa), 
VP16 (gggcgaaguuggacucgua), VP11/12 (ggacucagccggugacaua).
reverse Transfection and hcMV infection 
of Mrc-5 Fibroblasts
MRC-5 cells were seeded in Corning® 384-Well Optical Imaging 
Flat Clear Bottom Black Polystyrene TC-Treated Microplates 
(Corning Inc., Corning, NY, USA) in complete DMEM media 
and reverse-transfected, in accordance to the manufacturer’s 
instructions, using 0.2% DharmaFECT-1 (GE Dharmacon) 
and 25  nM siRNA (individual duplexes from deconvoluted 
SMARTpools, GE Dharmacon) in a 60  µl final well volume 
(concentrations indicated are final concentrations). For The 
Human GPCR SMARTpool library screen of siRNA-transfected 
cells, three completely independent screens were prepared using 
technical duplicates, giving a final number of n = 6. To determine 
effects by the individual siRNAs and cell viability in parallel, half 
of the plate was used for viral infection and the other half, left 
uninfected, was used to determine cell viability.
For deconvoluted siRNA screens, three identical replicate 
plates were prepared with siRNA-transfected cells, from 
which one was used for cell viability (uninfected), and two 
were subsequently infected to determine the effects on viral 
replication. In short, 3 × 103 cells were seeded in a volume of 
40 µl/well in 384-well plates containing 10 µl DharmaFECT-1 
diluted in Hanks Balanced Salt Solution (HSBB) (Lonza AG) 
and 10 µl siRNA diluted in 1× siRNA buffer (GE Dharmacon). 
Transfected cells were allowed to recover for 48  h before 
infection with HCMV. Following reverse transfection, MRC-5 
fibroblasts were infected with AD169-GFP HCMV virus (147) 
at an MOI (0.5), diluted in phenol-red-free complete DMEM 
media.
analysis of Viral replication and cell 
Viability assay
For The Human GPCR SMARTpool library screen three plates 
were simultaneously prepared and half of each plate was 
infected. Virus and cell viability measurements for each plate 
were simultaneously measured once as an endpoint at 40, 70, 
or 94  h postinfection. For deconvoluted siRNA screens, cells 
viability was measured in every screen repeat using a dedicated 
replica plate at 48 h post-transfection, while viral replication of 
the remaining two plates were measured repeated for GFP over 
time-course, to calculate slope values of GFP expression. Linear 
regression was applied to determine the viral replication (slope) 
between 30–75  h postinfection. For both The Human GPCR 
SMARTpool library screen and the screen with the deconvoluted 
siRNAs, cell viability was measured in using a dilution of 5  µl 
CellTiter Blue (G8080, Promega, Madison, WI, USA) in 60  µl 
phenol red-free DMEM (Lonza AG), supplemented as described 
above, in a 384-well plate. Cell viability was assayed by measuring 
levels of fluorescent resorufin produced by metabolically active 
cells using a BMG LABTECH POLARstar Optima plate reader 
(fluorescence bottom-read; excitation filter A-560; emission 
filter 590; gain set to 1,500). For siRNA screens, cell viability was 
measured in every screen repeat using a dedicated replica plate at 
48 h post-transfection (the remaining two replica plates in each 
screen repeat were then infected and assayed for virus replication 
rate as described above).
analysis of the human gPcr sMarTpool 
rnai screen Data
Subsequent to averaging technical replicate runs for each 
biologically independent screen, analysis-ready data consist of 
measured viral growth slopes for each gene in three independ-
ent biological replicate experiments. Using R Language and 
Environment for Statistical Computing (135), we aimed to 
identify suppressed genes that result in a consistently high or 
low ranking (with respect to other genes in a given biologically 
independent experiment run) of their viral growth slope across 
all three biologically independent runs. We use a Rank Product 
(148) one-class test statistic to obtain a significance estimate 
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